Dr Alysson Wann - Medical Oncologist
Dr Alysson Wann trained at major Melbourne hospitals including Olivia Newton Cancer Centre where she completed her fellowship in breast and gastrointestinal cancers. She went on to complete her Masters degree in Public Health, specialising in health in the ageing population.
In her spare time, Alysson enjoys spending time with her young family. She is bilingual and can consult in Burmese also.
​
Consulting rooms:
Mount Waverley
​
Admission rights:
Waverley Private
Epworth Eastern
Epworth Richmond
​
Public positions (Consultant medical oncologist):
Eastern Health
Research
Dr Wann is dedicated to research and academics, working as a Clinical Lecturer with the University of Melbourne Medical School. She also continues to be actively involved in cancer research with multiple publications in peer reviewed journals, presentations at international conferences and was awarded an ASCO (Amercian Society of Clinical Oncology) Merit Award.
​
A Wann, H Gan, K Drummond, L Jeffree, Z Lwin, M Khasraw
Outcomes after second surgery for recurrent glioblastoma: a retrospective case–control study.
J Neurooncol. 2018 Apr;137(2):409-415
A Wann, D Ashley, M Khasraw
Use of targeted therapy in cancer patients in the end-of-life period: results from an Australian
centre. Support Care Cancer. 2016, Vol 24, (7), 3023-3028
A Wann, Newnham G.
Real world use of maintenance chemotherapy in advanced Non-Small Cell Lung Cancer in an
Australian Cancer Centre. World Journal of Oncology, Vol. 3, No. 6, Dec 2012
Nguyen M, Ng Ying Kin S, Shum E, Wann A, Tamjid B, Sahu A, Torres J.
Anticancer therapy within the last 30 days of life: results of an audit and re-audit cycle from an Australian regional cancer centre.
BMC Palliat Care. 2020;19(1):14. Published 2020 Jan 27. doi:10.1186/s12904-020-0517-3
JA McCracken, A Wann, S Wann, M Chou, F Faroudi, S White, B Yeo.
Neoadjuvant management of breast cancer. 10 years of experience at a single centre.
Manuscript in progress
Nguyen, M. Shum, E. Ng Ying Kin, S. Wann, A. Tamjid, B. Torres, J.
Anticancer therapy within the last 30 days of life in a regional cancer centre.
- ESMO 2018 (Annals of Oncology (2018) 29 (suppl_8): viii603-viii640. 10.1093/annonc/mdy300)
- MASCC-ISOO 2018 (Vienna, Austria) – Poster Presentation
- APJCO (2019) https://doi.org/10.1111/ajco.13018
Nguyen, M. Jacobson, T. Torres, J. Tamjid, B. Wann, A.
Potential length of stay reduction with outpatient management of low risk febrile neutropenia.
- APJCO (July 2018) https://doi.org/10.1111/ajco.13018
​
A Wann, S Luen, B Yeo, S White
Breath alcohol concentrations in patients undergoing taxane chemotherapy: an observational
pilot study (BrACT study)
European Society of Medical Oncology – Asia 2017 (Singapore) – Poster Presentation
A Wann, H Gan, K Drummond, L Jeffree, Z Lwin, M Khasraw
Outcomes of second surgery in patients with GBM – multi-center retrospective study.
Neuro Oncol (2016) 18 (suppl_6): vi192
Society for Neuro-Oncology Annual Scientific Meeting 2016 (Arizona, USA) – Poster Presentation
- Cooperative Trials Group for Neuro-Oncology Annual Scientific Meeting 2015 – Poster Presentation
A Wann, S Wann, E Liow, J Stewart, F Barnett, B Yeo
A decade of giving neoadjuvant therapy in an Australian breast cancer setting: what have we
learned?
- Clinical Oncology Society of Australia 2016 – Poster presentation.
- APJCO (Nov 2016) https://doi.org/10.1111/ajco.12646
A Wann, D Ashley, M Khasraw
Use of targeted therapy in cancer patients in the end-of-life period: results from an Australian
centre.
- J Clin Oncol 32, 2014 (suppl 31; abstr 129)
- ASCO Palliative Care Symposium 2014 (Boston, USA) – Poster Presentation
- Barwon Health Research Week 2014 – Poster Presentation.
A Wann, Newnham G.
Real world use of maintenance chemotherapy in advanced Non-Small Cell Lung Cancer in an
Australian Cancer Centre. Journal of Thoracic Oncology, Vol 7, No 9, Sept 2012
- Australian Lung Cancer Conference 2012 - Poster Presentation
- St Vincent’s Hospital Research Week 2012 – Poster Presentation